Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Peter Dansky

Premium

Peter Dansky has joined Agena Bioscience as CEO and a member of its board of directors. San Diego-based Agena recently acquired Sequenom's genetic analysis business, including its MassArray platform, and Dansky will lead the company into new application areas including clinical diagnostics.

He joins Agena from Life Technologies, where he was president of its molecular and cell biology division. Before that, he held management positions at Affymetrix, Millipore, Molecular Dynamics, and other companies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.